89bio, Inc. Deferred Tax Assets, Net of Valuation Allowance
89bio, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $516.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-02-27
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $516.00K.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $715.00K.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $319.00K.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $219.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-12-31 | $516.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $715.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $319.00K 10-K · filed 2024-03-01 |
| 2021-12-31 | $219.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $69.00K 10-K · filed 2022-03-24 |
| 2018-12-31 | $20.00K 10-K · filed 2020-03-18 |